Phaim Pharma Ltd.

Organization

London, GB

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
CTLA4 fusion proteins for the treatment of diabetes
- Patent number 11,286,303
- Issue date Mar 29, 2022
- Phaim Pharma Ltd
- Tihamer Orban
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunomodulatory therapy for type 1 diabetes mellitus autoimmunity
- Patent number 11,040,093
- Issue date Jun 22, 2021
- Phaim Pharma Ltd
- Tihamer Orban
- G01 - MEASURING TESTING

Patents Applicationslast 30 patents

Information Patent Application
Psoriasis and Other Autoimmune Diseases Antigen Immune Modulator (A...
- Publication number 20240361217
- Publication date Oct 31, 2024
- PHAIM PHARMA LTD
- Tihamer ORBAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Immunomodulatory Therapy For Type 1 Diabetes Mellitus Autoimmunity
- Publication number 20240316168
- Publication date Sep 26, 2024
- PHAIM PHARMA LTD
- Tihamer ORBAN
- G01 - MEASURING TESTING
Information Patent Application
Patient Profiling for Antigen-Specific Immunomodulatory Therapies
- Publication number 20240285732
- Publication date Aug 29, 2024
- PHAIM PHARMA LTD
- Tihamer ORBAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combinations of Modalities for the Treatment of Diabetes
- Publication number 20240058442
- Publication date Feb 22, 2024
- Phaim Pharma Ltd.
- Tihamer ORBAN
- G01 - MEASURING TESTING
Information Patent Application
Diabetes Biomarkers
- Publication number 20230333094
- Publication date Oct 19, 2023
- PHAIM PHARMA LTD
- Tihamer ORBAN
- G01 - MEASURING TESTING
Information Patent Application
PSORIASIS AND OTHER AUTOIMMUNE DISEASES ANTIGEN IMMUNE MODULATOR (A...
- Publication number 20210404921
- Publication date Dec 30, 2021
- PHAIM PHARMA LTD
- TIHAMER ORBAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOMODULATORY THERAPY FOR TYPE 1 DIABETES MELLITUS AUTOIMMUNITY
- Publication number 20210353727
- Publication date Nov 18, 2021
- PHAIM PHARMA LTD
- TIHAMER ORBAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
90770788 - PHAIM AIM ANTIGENIC IMMUNE MODULATION
- Serial number 90770788
- Registration number 6842815
- Filing date Jun 12, 2021
- Phaim Pharma Ltd.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90208791
- Serial number 90208791
- Registration number 6347931
- Filing date Sep 24, 2020
- Phaim Pharma Ltd.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90208767 - PHAIM
- Serial number 90208767
- Registration number 7342040
- Filing date Sep 24, 2020
- Phaim Pharma Ltd.
- 5 - Pharmaceutical and veterinary preparations

Phaim Pharma Ltd.

Organization

Patents Grantslast 30 patents

CTLA4 fusion proteins for the treatment of diabetes

Immunomodulatory therapy for type 1 diabetes mellitus autoimmunity

Patents Applicationslast 30 patents

Psoriasis and Other Autoimmune Diseases Antigen Immune Modulator (A...

Immunomodulatory Therapy For Type 1 Diabetes Mellitus Autoimmunity

Patient Profiling for Antigen-Specific Immunomodulatory Therapies

Combinations of Modalities for the Treatment of Diabetes

Diabetes Biomarkers

PSORIASIS AND OTHER AUTOIMMUNE DISEASES ANTIGEN IMMUNE MODULATOR (A...

IMMUNOMODULATORY THERAPY FOR TYPE 1 DIABETES MELLITUS AUTOIMMUNITY

Trademarklast 30 trademarks

90770788 - PHAIM AIM ANTIGENIC IMMUNE MODULATION

90208791

90208767 - PHAIM